Stem Cell Therapy for Ischemic Heart Disease: A Status Report
Journal of the Korean Medical Association
; : 926-932, 2004.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-145587
Biblioteca responsável:
WPRO
ABSTRACT
Myocardial infarction is the leading cause of congestive heart failure and deaths in developed countries. Current therapy is limited to the prevention of the progression of ventricular remodeling. The transplantation of stem cells into the injured myocardium is a novel and promising approach for the restoration of myocardial function. Various animal studies have suggested the potential of stem cell transplantation to regenerate myocardium and to improve cardiac function. Recently early phase I clinical studies show that stem cell therapy may have beneficial effects on ventricular remodeling. In this article, the state of the art in both laboratory and clinic on myocardial regeneration with various types of stem cells is introduced. Finally the current and intrinsic limitations of stem cell therapy are discussed along with future directions for research on stem cell therapy for ischemic heart diseases.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Doença Cardiovascular
/
Doença Isquêmica do Coração
/
Outras Doenças Circulatórias
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Regeneração
/
Células-Tronco
/
Países Desenvolvidos
/
Isquemia Miocárdica
/
Remodelação Ventricular
/
Transplante de Células-Tronco
/
Insuficiência Cardíaca
/
Infarto do Miocárdio
/
Miocárdio
Limite:
Animais
Idioma:
Coreano
Revista:
Journal of the Korean Medical Association
Ano de publicação:
2004
Tipo de documento:
Artigo